Effect of tenapanor on interdialytic weight gain in patients on hemodialysis

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 9, 2016, Pages 1597-1605

  Block, Geoffrey A ^a   Rosenbaum, David P ^b   Leonsson Zachrisson, Maria ^c   Stefansson, Bergur V ^c   Rydén Bergsten, Tina ^c   Greasley, Peter J ^c   Johansson, Susanne A ^c   Knutsson, Mikael ^c   Carlsson, Björn C ^c  

^a Denver Nephrology   (United States)

^b Ardelyx Inc   (United States)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Body Weight; Chronic kidney disease stage 5D; End stage renal disease; Humans; Renal Dialysis; Renal Insufficiency, Chronic; Sodium; Sodium Hydrogen Antiporter; Sodium hydrogen antiporter; Tenapanor; Weight Gain

Indexed keywords

PLACEBO; TENAPANOR; ISOQUINOLINE DERIVATIVE; SODIUM; SODIUM PROTON EXCHANGE PROTEIN 3; SULFONAMIDE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION; WEIGHT GAIN; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CHEMISTRY; CLINICAL TRIAL; DRUG EFFECTS; FECES; FEMALE; MALE; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; DIARRHEA; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; ISOQUINOLINES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SODIUM; SODIUM-HYDROGEN EXCHANGER 3; SULFONAMIDES; WEIGHT GAIN; YOUNG ADULT;

EID: 85007138824     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09050815     Document Type: Article

References (21)

1. Inrig JK, Patel UD, Gillespie BS, Hasselblad V, Himmelfarb J, Reddan D, Lindsay RM, Winchester JF, Stivelman J, Toto R, Szczech LA: Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis 50: 108-118, 2007
2. Stefánsson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stålhammar NO: Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol 9: 2124-2132, 2014
3. Holmberg B, Stegmayr BG: Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain. Hemodial Int 13: 27-31, 2009
4. Lee MJ, Doh FM, Kim CH, Koo HM, Oh HJ, Park JT, Han SH, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW: Interdialytic weight gain and cardiovascular outcome in incident hemodialysis patients. Am J Nephrol 39: 427-435, 2014
5. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC: Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119: 671-679, 2009
6. Kayikcioglu M, Tumuklu M, Ozkahya M, Ozdogan O, Asci G, Duman S, Toz H, Can LH, Basci A, Ok E: The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 24: 956-962, 2009
7. Maduell F, Navarro V: Dietary salt intake and blood pressure control in haemodialysis patients. Nephrol Dial Transplant 15: 2063, 2000
8. Anonymous: Chapter 3: Management of progression and complications of CKD. Kidney Int Suppl (2011) 3: 73-90, 2013
9. K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 [Suppl 3]: S1-S153, 2005
10. Ozkahya M, Toz H, Qzerkan F, Duman S, Ok E, Basci A, Mees EJ: Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 15: 655-660, 2002
11. Broere N, Chen M, Cinar A, Singh AK, Hillesheim J, Riederer B, Lünnemann M, Rottinghaus I, Krabbenhöft A, Engelhardt R, Rausch B, Weinman EJ, Donowitz M, Hubbard A, Kocher O, de Jonge HR, Hogema BM, Seidler U: Defective jejunal and colonic salt absorption and alteredNa(+)/H (+) exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor proteindeficient mice. Pflugers Arch 457: 1079-1091, 2009
12. Orlowski J, Kandasamy RA, Shull GE: Molecular cloning of putative members of the Na/H exchanger gene family. cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the ratNa/HexchangerNHE-1 and two structurally related proteins. J Biol Chem 267: 9331-9339, 1992
13. Tse CM, Brant SR, Walker MS, Pouyssegur J, Donowitz M: Cloning and sequencing of a rabbit cDNA encoding an intestinal and kidney-specific Na+/H+ exchanger isoform (NHE-3). J Biol Chem 267: 9340-9346, 1992
14. Spencer AG, Labonte ED, Rosenbaum DP, Plato CF, Carreras CW, Leadbetter MR, Kozuka K, Kohler J, Koo-McCoy S, He L, Bell N, Tabora J, Joly KM, Navre M, Jacobs JW, Charmot D: Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans. Sci Transl Med 6: 227ra36, 2014
15. Lewis SJ, Heaton KW: Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32: 920-924, 1997
16. Santos SF, Peixoto AJ: Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol 3: 522-530, 2008
17. Hecking M, Karaboyas A, Saran R, Sen A, Inaba M, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK: Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol 7: 92-100, 2012
18. Weiner DE, Brunelli SM, Hunt A, Schiller B, Glassock R, Maddux FW, Johnson D, Parker T, Nissenson A: Improving clinical outcomes among hemodialysis patients: A proposal for a “volume first” approach from the chief medical officers of US dialysis providers. Am J Kidney Dis 64: 685-695, 2014
19. Munoz Mendoza J, Bayes LY, Sun S, Doss S, Schiller B: Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly incenter nocturnal hemodialysis: A quality improvement study. Am J Kidney Dis 58: 956-963, 2011
20. Dahlmann A, Dörfelt K, Eicher F, Linz P, Kopp C, Mössinger I, Horn S, Büschges-Seraphin B, Wabel P, Hammon M, Cavallaro A, Eckardt KU, Kotanko P, Levin NW, Johannes B, Uder M, Luft FC, Müller DN, Titze JM: Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients. Kidney Int 87: 434-441, 2015
21. Agarwal R, Flynn J, Pogue V, Rahman M, Reisin E, Weir MR: Assessment and management of hypertension in patients on dialysis. J Am Soc Nephrol 25: 1630-1646, 2014